Icometrix's icobrain AI software is designed to help radiologists and neurologists quantify and track different brain abnormalities on MRI scans. Information is presented in a report that includes healthy control data to aid in the interpretation and communication of results.

Affidea will implement a new AI tool, known as icobrainms, to monitor disease progression and help assess MS patients to improve their treatment and follow-up care.

The pilot program will launch in Italy, Portugal, Switzerland, and Serbia.